Madeleine Armstrong

Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021.

Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021.

Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021.

Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021.

Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021.

Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021.